Impact of the metalloproteinase-9/tissue inhibitor of metalloproteinase-1 system on large arterial stiffness in patients with essential hypertension

Hypertension Research

Volumn 30, Issue 10, 2007, Pages 959-963

  Tan, Jing ^a   Hua, Qi ^a   Xing, Xiurong ^a   Wen, Jing ^a   Liu, Rongkun ^a   Yang, Zheng ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Hypertension; Large arterial stiffness; Metalloproteinase 9; Pulse wave velocity; Tissue inhibitor of metalloproteinase 1

Indexed keywords

ANTIHYPERTENSIVE AGENT; BIOLOGICAL MARKER; GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; AGED; ARTERY COMPLIANCE; ARTICLE; CAROTID ARTERY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESSENTIAL HYPERTENSION; FEMALE; FEMORAL ARTERY; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREDICTION; PROTEIN BLOOD LEVEL; PULSE WAVE; RADIAL ARTERY; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; AGED, 80 AND OVER; ARTERIES; CD40 LIGAND; ELASTICITY; FEMALE; HUMANS; HYPERTENSION; INTERLEUKIN-6; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PULSE; REGRESSION ANALYSIS; STATISTICS, NONPARAMETRIC; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 36249017215     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.30.959     Document Type: Article

References (19)

1. Grundy SM: Inflammation, hypertension, and the metabolic syndrome. JAMA 2003; 290: 3000-3002.
2. Amar J, Ruidavets JB, Chamontin B, Drouet L, Ferrieres J: Arterial stiffness and cardiovascular risk factors in a population-based study. J Hypertens 2001; 19: 381-387.
3. Laurent S, Boutouyrie P, Asmar R, et al: Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37: 1236-1241.
4. Asmar R, Rudnichi A, Blacher J, London GM, Safar ME: Pulse pressure and aortic pulse wave are markers of cardiovascular risk in hypertensive populations. Am J Hypertens 2001; 14: 91-97.
5. Asmar R, Benctos A, Topouchian J, et al: Assessment of arterial distensibility by automatic pulse wave velocity measurement: validation and clinical application studies. Hypertension 1995; 26: 485-490.
6. Ni Y, Wang H, Hu D, Zhang W: The relationship between pulse wave velocity and pulse pressure in Chinese patients with essential hypertension. Hypertens Res 2003; 26: 871-874.
7. Bland JM, Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307-310.
8. Visse R, Nagase H: Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 2003; 92: 827-839.
9. Rodriguez-Pla A, Bosch-Gil JA, Rossello-Urgell J, Huguet-Redecilla P, Stone JH, Vilardell-Tarres M: Metalloproteinase-2 and -9 in giant cell arteritis: involvement in vascular remodeling. Circulation 2005; 112: 264-269.
10. Yasmin, McEniery CM, Wallace S, et al.: Matrix metallo proteinase-9 (MMP-9), MMP-2, and serum etastase activity are associated with systolic hypertension and arterial stiffness. Arterioscler Thromb Vasc Biol 2005; 25: 372-378.
11. Karakaya O, Barutcu I, Esen AM, et al: Relationship between circulating plasma matrix metalloproteinase-9 (gelatinase-B) concentration and aortic root dilatation. Am J Hypertens 2006; 19: 361-365.
12. Jacob MP: Extracellular matrix remodeling and matrix metalloproteinases in the vascular wall during aging and in pathological conditions. Biomed Pharmacother 2003; 57: 195-202.
13. Tayebjee MH, Nadar SK, Macfadyen RJ, Lip GY: Tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 levels in patients with hypertension. Relationship to tissue Doppler indices of diastolic relaxation. Am J Hypertens 2004; 17: 770-774.
14. Lindsay MM, Maxwell P, Dunn FG: TIMP-1: a marker of left ventricular diastolic dysfunction and fibrosis in hypertension. Hypertension 2002; 40: 136-141.
15. Bouvet C, Gilbert LA, Girardot D, deBlois D, Moreau P: Different involvement of extracellular matrix components in small and large arteries during chronic NO synthase inhibition. Hypertension 2005; 45: 432-437.
16. Boutouyrie P, Laurent S, Benetos A, Girerd XJ, Hoeks AP, Safar ME: Opposing effects of aging on distal and proximal large arteries in hypertensives. J Hypertens Suppl 1992; 10: S87-S89.
17. Fichtlscherer S, Heeschen C, Zeiher AM: Inflammatory markers and coronary artery disease. Curr Opin Pharmacol 2004; 4: 124-131.
18. Chua CC, Hamdy RC, Chua BH: Angiotensin II induces TIMP-1 production in rat heart endothelial cells. Biochim Biophys Acta 1996; 1311: 175-180.
19. Ishikawa J, Kario K, Matsui Y, et al: Collagen metabolism in extracellular matrix may be involved in arterial stiffness in older hypertensive patients with left ventricular hypertrophy. Hypertens Res 2005; 28: 995-1001.